NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

文明病治療藥市場規模調查:各治療類型,各形態,各流通管道-至2025年的世界預測-COVID-19累積的影響

Lifestyle Drugs Market Research Report by Therapeutic Type, by Form, by Distribution, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 995294
出版日期 內容資訊 英文 184 Pages
商品交期: 最快1-2個工作天內
價格
文明病治療藥市場規模調查:各治療類型,各形態,各流通管道-至2025年的世界預測-COVID-19累積的影響 Lifestyle Drugs Market Research Report by Therapeutic Type, by Form, by Distribution, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 184 Pages
簡介

全球文明病治療藥的市場規模,預計從2020年的178億3256萬美元,至2025年末成長為225億3657萬美元。

COVID-19是影響幾乎全部產業的無與倫比的世界公共衛生緊急事件,在預測期間內預計帶給產業的成長長期性的影響。目前進行的調查擴大了框架,以確保包括潛在的COVID-19問題和發展途徑。 本報告提供有關COVID-19的見解,其中考慮了消費者行為和需求的變化,購買方式,供應鏈的新路由,當前市場力量的動態以及政府的重要介入等COVID-19對市場的影響相關洞察。更新的調查,考慮市場上COVID-19的影響,提供洞察,分析,估計,及預測。

本報告提供文明病治療藥市場調查,市場概要,市場成長要素及阻礙因素分析,各治療類型,各形態,各流通管道,各地區的市場規模的變化與預測,COVID-19累積的影響,競爭情形,主要企業的簡介,市場機會等全面性資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和涵蓋範圍
  • 調查對象年份
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 製作計劃:調查計劃
    • 實施實行:調查
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查成果

第3章 摘要整理

  • 市場預測
  • 治療類型預測
  • 泡沫預測
  • 流通預測
  • 地區展望
  • 其他競爭公司預測

第4章 市場概要

  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特五力分析
    • 新加入業者的威脅
    • 替代品的威脅
    • 客戶談判力
    • 供給企業談判力
    • 產業的競爭

第6章 全球文明病治療藥市場:各治療類型

  • 皮膚科
  • 失眠症
  • 肥胖
  • 性功能障礙
  • 抽煙
  • 女性的健康

第7章 文明病治療藥市場:各形態

  • 奶油
  • 凝膠
  • 口服糖漿
  • 非口服
  • 平板電腦

第8章 全球文明病治療藥市場:各流通管道

  • 醫院藥局
  • 線上管道
  • 零售藥局

第9章 南北美洲的文明病治療藥市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區的文明病治療藥市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第11章 歐洲,中東、非洲的文明病治療藥市場

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第12章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併和收購
    • 協定,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 獎,獎勵,擴大

第13章 企業的實用性簡介

  • Amgen Inc.
  • AstraZeneca plc
  • Biocon Limited
  • Dr. Reddy's Laboratories
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc., d.b.a.
  • Pfizer Inc.
  • Procter & Gamble Company
  • Teva Pharmaceutical Industries Ltd.

第14章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-436FCD7B1C9D

The Global Lifestyle Drugs Market size was estimated at USD 17.83 Billion in 2020 and expected to reach USD 18.77 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 5.63% to reach USD 24.77 Billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Lifestyle Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Therapeutic Type, the Lifestyle Drugs Market was studied across Dermatology, Insomnia, Obesity, Sexual Dysfunction, Smoking, and Women's Health.

Based on Form, the Lifestyle Drugs Market was studied across Creams, Gels, Oral Syrups, Parenteral, and Tablets.

Based on Distribution, the Lifestyle Drugs Market was studied across Hospital Pharmacies, Online Channels, and Retail Pharmacies.

Based on Geography, the Lifestyle Drugs Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Lifestyle Drugs Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Lifestyle Drugs Market, including Amgen Inc., AstraZeneca plc, Biocon Limited, Dr. Reddy's Laboratories, Eli Lilly and Company, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., d.b.a., Pfizer Inc., Procter & Gamble Company, and Teva Pharmaceutical Industries Ltd..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Lifestyle Drugs Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Lifestyle Drugs Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Lifestyle Drugs Market?
  • 4. What is the competitive strategic window for opportunities in the Global Lifestyle Drugs Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Lifestyle Drugs Market?
  • 6. What is the market share of the leading vendors in the Global Lifestyle Drugs Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Lifestyle Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Therapeutic Type Outlook
  • 3.4. Form Outlook
  • 3.5. Distribution Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Adoption of unhealthy eating habits and sedentary lifestyle
      • 5.1.1.2. Rising cases of obesity and associated diseases
      • 5.1.1.3. Increasing awareness regarding personal fitness and health consciousness
      • 5.1.1.4. Growth in sexual disorders and hormonal imbalance
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse effects associated with the lifestyle drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing R&D for drug developments
      • 5.1.3.2. Rising expenditure on beauty and skin care therapeutics
    • 5.1.4. Challenges
      • 5.1.4.1. Patient's ignorance towards early prevention & treatment of lifestyle related diseases
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Lifestyle Drugs Market, by Therapeutic Type

  • 6.1. Introduction
  • 6.2. Dermatology
  • 6.3. Insomnia
  • 6.4. Obesity
  • 6.5. Sexual Dysfunction
  • 6.6. Smoking
  • 6.7. Women's Health

7. Lifestyle Drugs Market, by Form

  • 7.1. Introduction
  • 7.2. Creams
  • 7.3. Gels
  • 7.4. Oral Syrups
  • 7.5. Parenteral
  • 7.6. Tablets

8. Lifestyle Drugs Market, by Distribution

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Channels
  • 8.4. Retail Pharmacies

9. Americas Lifestyle Drugs Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States
    • 9.6.1. California
    • 9.6.2. Florida
    • 9.6.3. Illinois
    • 9.6.4. New York
    • 9.6.5. Ohio
    • 9.6.6. Pennsylvania
    • 9.6.7. Texas

10. Asia-Pacific Lifestyle Drugs Market

  • 10.1. Introduction
  • 10.2. China
  • 10.3. India
  • 10.4. Indonesia
  • 10.5. Japan
  • 10.6. Malaysia
  • 10.7. Philippines
  • 10.8. South Korea
  • 10.9. Thailand

11. Europe, Middle East & Africa Lifestyle Drugs Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Quadrant
  • 12.4. Market Share Analysis, By Company
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. Amgen Inc.
  • 13.2. AstraZeneca plc
  • 13.3. Biocon Limited
  • 13.4. Dr. Reddy's Laboratories
  • 13.5. Eli Lilly and Company
  • 13.6. GlaxoSmithKline plc
  • 13.7. Johnson & Johnson
  • 13.8. Merck & Co., Inc., d.b.a.
  • 13.9. Pfizer Inc.
  • 13.10. Procter & Gamble Company
  • 13.11. Teva Pharmaceutical Industries Ltd.

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
  • 14.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL LIFESTYLE DRUGS MARKET SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 2. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2020 (USD BILLION)
  • FIGURE 3. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2020 (USD BILLION)
  • FIGURE 4. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2020 (USD BILLION)
  • FIGURE 5. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
  • FIGURE 6. GLOBAL LIFESTYLE DRUGS MARKET: MARKET DYNAMICS
  • FIGURE 7. GLOBAL LIFESTYLE DRUGS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 8. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2020 VS 2026 (%)
  • FIGURE 9. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2020 VS 2026 (USD BILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2026
  • FIGURE 11. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY DERMATOLOGY, 2018-2026 (USD BILLION)
  • FIGURE 12. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY DERMATOLOGY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 13. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY INSOMNIA, 2018-2026 (USD BILLION)
  • FIGURE 14. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY INSOMNIA, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 15. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY OBESITY, 2018-2026 (USD BILLION)
  • FIGURE 16. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY OBESITY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 17. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY SEXUAL DYSFUNCTION, 2018-2026 (USD BILLION)
  • FIGURE 18. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY SEXUAL DYSFUNCTION, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 19. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY SMOKING, 2018-2026 (USD BILLION)
  • FIGURE 20. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY SMOKING, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 21. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY WOMEN'S HEALTH, 2018-2026 (USD BILLION)
  • FIGURE 22. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY WOMEN'S HEALTH, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 23. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2020 VS 2026 (%)
  • FIGURE 24. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2020 VS 2026 (USD BILLION)
  • FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2026
  • FIGURE 26. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY CREAMS, 2018-2026 (USD BILLION)
  • FIGURE 27. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY CREAMS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 28. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY GELS, 2018-2026 (USD BILLION)
  • FIGURE 29. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY GELS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 30. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY ORAL SYRUPS, 2018-2026 (USD BILLION)
  • FIGURE 31. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY ORAL SYRUPS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 32. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2026 (USD BILLION)
  • FIGURE 33. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY PARENTERAL, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 34. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY TABLETS, 2018-2026 (USD BILLION)
  • FIGURE 35. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY TABLETS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 36. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2020 VS 2026 (%)
  • FIGURE 37. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2020 VS 2026 (USD BILLION)
  • FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2026
  • FIGURE 39. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2026 (USD BILLION)
  • FIGURE 40. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 41. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY ONLINE CHANNELS, 2018-2026 (USD BILLION)
  • FIGURE 42. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY ONLINE CHANNELS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 43. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2026 (USD BILLION)
  • FIGURE 44. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 45. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 46. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 47. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 48. ARGENTINA LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 49. BRAZIL LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 50. CANADA LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 51. MEXICO LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 52. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 53. CALIFORNIA LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 54. FLORIDA LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 55. ILLINOIS LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 56. NEW YORK LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 57. OHIO LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 58. PENNSYLVANIA LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 59. TEXAS LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 60. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 61. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 63. CHINA LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 64. INDIA LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 65. INDONESIA LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 66. JAPAN LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 67. MALAYSIA LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 68. PHILIPPINES LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 69. SOUTH KOREA LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 70. THAILAND LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 71. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 72. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 73. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 74. FRANCE LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 75. GERMANY LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 76. ITALY LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 77. NETHERLANDS LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 78. QATAR LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 79. RUSSIA LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 80. SAUDI ARABIA LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 81. SOUTH AFRICA LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 82. SPAIN LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 83. UNITED ARAB EMIRATES LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 84. UNITED KINGDOM LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 85. GLOBAL LIFESTYLE DRUGS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 86. GLOBAL LIFESTYLE DRUGS MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 87. GLOBAL LIFESTYLE DRUGS MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 88. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL LIFESTYLE DRUGS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL LIFESTYLE DRUGS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 4. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY DERMATOLOGY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 5. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY INSOMNIA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 6. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY OBESITY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 7. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY SEXUAL DYSFUNCTION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 8. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY SMOKING, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 9. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY WOMEN'S HEALTH, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 10. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 11. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY CREAMS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 12. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY GELS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 13. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY ORAL SYRUPS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 14. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY PARENTERAL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 15. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY TABLETS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 16. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 17. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 18. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY ONLINE CHANNELS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 19. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 20. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 21. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 22. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 23. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 24. ARGENTINA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 25. ARGENTINA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 26. ARGENTINA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 27. BRAZIL LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 28. BRAZIL LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 29. BRAZIL LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 30. CANADA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 31. CANADA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 32. CANADA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 33. MEXICO LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 34. MEXICO LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 35. MEXICO LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 36. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 37. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 38. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 39. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 40. CALIFORNIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 41. CALIFORNIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 42. CALIFORNIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 43. FLORIDA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 44. FLORIDA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 45. FLORIDA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 46. ILLINOIS LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 47. ILLINOIS LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 48. ILLINOIS LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 49. NEW YORK LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 50. NEW YORK LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 51. NEW YORK LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 52. OHIO LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 53. OHIO LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 54. OHIO LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 55. PENNSYLVANIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 56. PENNSYLVANIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 57. PENNSYLVANIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 58. TEXAS LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 59. TEXAS LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 60. TEXAS LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 61. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 62. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 63. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 64. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 65. CHINA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 66. CHINA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 67. CHINA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 68. INDIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 69. INDIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 70. INDIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 71. INDONESIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 72. INDONESIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 73. INDONESIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 74. JAPAN LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 75. JAPAN LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 76. JAPAN LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 77. MALAYSIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 78. MALAYSIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 79. MALAYSIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 80. PHILIPPINES LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 81. PHILIPPINES LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 82. PHILIPPINES LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 83. SOUTH KOREA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 84. SOUTH KOREA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 85. SOUTH KOREA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 86. THAILAND LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 87. THAILAND LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 88. THAILAND LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 93. FRANCE LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 94. FRANCE LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 95. FRANCE LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 96. GERMANY LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 97. GERMANY LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 98. GERMANY LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 99. ITALY LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 100. ITALY LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 101. ITALY LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 102. NETHERLANDS LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 103. NETHERLANDS LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 104. NETHERLANDS LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 105. QATAR LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 106. QATAR LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 107. QATAR LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 108. RUSSIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 109. RUSSIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 110. RUSSIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 111. SAUDI ARABIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 112. SAUDI ARABIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 113. SAUDI ARABIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 114. SOUTH AFRICA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 115. SOUTH AFRICA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 116. SOUTH AFRICA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 117. SPAIN LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 118. SPAIN LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 119. SPAIN LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 120. UNITED ARAB EMIRATES LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 121. UNITED ARAB EMIRATES LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 122. UNITED ARAB EMIRATES LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 123. UNITED KINGDOM LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 124. UNITED KINGDOM LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 125. UNITED KINGDOM LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 126. GLOBAL LIFESTYLE DRUGS MARKET: SCORES
  • TABLE 127. GLOBAL LIFESTYLE DRUGS MARKET: BUSINESS STRATEGY
  • TABLE 128. GLOBAL LIFESTYLE DRUGS MARKET: PRODUCT SATISFACTION
  • TABLE 129. GLOBAL LIFESTYLE DRUGS MARKET: RANKING
  • TABLE 130. GLOBAL LIFESTYLE DRUGS MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 131. GLOBAL LIFESTYLE DRUGS MARKET: SHARE, BY COMPANY, 2020
  • TABLE 132. GLOBAL LIFESTYLE DRUGS MARKET: MERGER & ACQUISITION
  • TABLE 133. GLOBAL LIFESTYLE DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 134. GLOBAL LIFESTYLE DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 135. GLOBAL LIFESTYLE DRUGS MARKET: INVESTMENT & FUNDING
  • TABLE 136. GLOBAL LIFESTYLE DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 137. GLOBAL LIFESTYLE DRUGS MARKET: LICENSE & PRICING
  • TABLE 138. GLOBAL LIFESTYLE DRUGS MARKET: CONTACT DETAILS